Altrinsic Global Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Altrinsic Global Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-111,300	Closed	-$3.1M	–	88
2018 Q3	$3.1M	Sell	111,300 -18,388	-14%	-$517K	0.14%	54
2018 Q2	$3.62M	Sell	129,688 -46,612	-26%	-$1.25M	0.14%	58
2018 Q1	$4.38M	Hold	176,300	–	–	0.18%	49
2017 Q4	$4.27M	Hold	176,300	–	–	0.16%	52
2017 Q3	$4.87M	Sell	176,300 -250,000	-59%	-$6.67M	0.18%	51
2017 Q2	$10.7M	Sell	426,300 -10,000	-2%	-$248K	0.39%	47
2017 Q1	$11.7M	Sell	436,300 -30,000	-6%	-$829K	0.4%	48
2016 Q4	$12.2M	Sell	466,300 -60,000	-11%	-$1.48M	0.45%	44
2016 Q3	$13.2M	Sell	526,300 -100,000	-16%	-$2.33M	0.48%	46
2016 Q2	$13.6M	Hold	626,300	–	–	0.38%	47
2016 Q1	$9.39M	Sell	626,300 -100,000	-14%	-$1.68M	0.26%	53
2015 Q4	$15.9M	Sell	726,300 -60,000	-8%	-$1.12M	0.41%	48
2015 Q3	$12.4M	Buy	786,300 +40,000	+5%	+$641K	0.29%	48
2015 Q2	$10.7M	Buy	746,300 +80,000	+12%	+$1.35M	0.22%	49
2015 Q1	$11.5M	Hold	666,300	–	–	0.25%	46
2014 Q4	$11.9M	Hold	666,300	–	–	0.25%	48
2014 Q3	$8.75M	Hold	666,300	–	–	0.17%	51
2014 Q2	$9.57M	Hold	666,300	–	–	0.17%	54
2014 Q1	$8.49M	Hold	666,300	–	–	0.15%	53
2013 Q4	$6.66M	Buy	666,300 +150,000	+29%	+$1.7M	0.12%	53
2013 Q3	$6.79M	Buy	516,300 +31,300	+6%	+$411K	0.12%	51
2013 Q2	$6.93M	Buy	+485,000	New	+$6.1M	0.12%	49

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altrinsic Global Advisors's NXTM Position: Q4 2018 in Review

Altrinsic Global Advisors sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 111,300 shares — an estimated $3.1M sold.

Altrinsic Global Advisors first reported a position in NXTM in Q2 2013 and held it in 22 quarters. The position peaked at $15.9M in Q4 2015. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

Altrinsic Global Advisors reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
Altrinsic Global Advisors sold 111,300 NxStage Medical Inc. shares in Q4 2018, an estimated $3.1M.
Altrinsic Global Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 22 quarters.
Altrinsic Global Advisors's NxStage Medical Inc. position peaked at $15.9M in Q4 2015.
172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Altrinsic Global Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.